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ABSTRACT Methylation of 2-deoxyuridine-5ʹ-monophosphate (dUMP) at the C5 position by the 
obligate dimeric thymidylate synthase (TSase) in the sole de novo biosynthetic pathway to dTMP 
proceeds by forming a covalent ternary complex with dUMP and co-substrate 5,10-
methylenetetrahydrofolate. The crystal structure of an analog of this intermediate gives important 
mechanistic insights but does not explain the half-of-the sites activity of the enzyme. Recent 
experiments showed that the C5 proton and the catalytic Cys are eliminated in a concerted manner 
from the covalent ternary complex to produce a noncovalent bisubstrate intermediate. Here we 
report the crystal structure of TSase with a close synthetic analog of this intermediate in which it 




activity of this enzyme. Quantum mechanics/molecular mechanics simulations confirmed that the 
analog could undergo catalysis. The crystal structure shows a new water 2.9 Å from the critical C5 
of the dUMP moiety, which, in conjunction with other residues in the network, may be the elusive 
general base that abstracts the C5 proton of dUMP during the reaction. 
Thymidylate synthase (TSase) methylates 2-deoxyuridine-5ʹ-monophosphate (dUMP) to produce 
thymidylate (dTMP), a building block of DNA. Since TSase is the sole de novo source of dTMP 
it is essential in dividing cells and hence is an anti-cancer target.1 A minimal mechanism has 
been proposed for the reaction in which Michael addition of the catalytic Cys146 to C6 of the 
dUMP pyrimidine ring activates C5 for addition to the N5-methylene of the co-substrate 5,10-
methylenetetrahydrofolate (CH2H4F) (Figure 1A, step 1), producing a covalent ternary complex 
between protein, dUMP and CH2H4F (this intermediate we term Int). In this proposed 
mechanism, the Cys is eliminated during the final (hydride transfer) step of the reaction 
(pathway A).2 Much of the current understanding of TSase mechanism derives from its covalent 
ternary complex with CH2H4folate and the mechanism-based inhibitor 5-fluoro-dUMP (FdUMP) 
(Figure 1B and 1C).2 This structure is a close analog of Int: the replacement of hydrogen at the 
critical C5 methylation site by fluorine stalls the reaction before resolution of the complex into 
tetrahydrofolate (H4F) and the covalent exocyclic methylene intermediate. Despite the high 
similarity of the FdUMPCH2H4F complex to the naturally occurring Int, the atomic details of 
this structure might not represent those of the analogous complex formed during the reaction.3 
Specifically, EcTSase is a half-sites active homodimer,4 but, seemingly inconsistent with this 
half-the-sites activity  (or simply reflecting random substitutions of half-the-sites activated 
dimers), the structure of the intermediate analog structure is apparently two-fold symmetric. 




network of residues consisting of Tyr94, Glu58, His147 and Asn177 and water molecules 
connected by H-bonds was suggested to serve as a general base.5 No crystal structure, including 
that of the FdUMPCH2H4F complex, features a continuous H-bond network between all the 
residues involved in the proton transfer site.
 
Figure 1. A. Mechanism of TSase catalyzed reaction. B. Inhibition of TSase by FdUMP. C. 
Structure of EcTSase (PDB 1TLS) with covalently bound FdUMPCH2H4F (a mimic of Int) 
showing several important active site residues and water molecules. H-Bonds are drawn in cyan. 
 Recently, based on quantum mechanics/molecular mechanics (QM/MM) calculations, a 
modification of the TSaseʹs mechanism was proposed in which the proton at C5 of dUMP and 
the catalytic Cys are eliminated in a concerted manner from Int (Figure 1, step 2B), leaving a 
noncovalent bisubstrate intermediate Int-B.3, 6 This proposal was supported when Int-B was 
synthesized and shown to be a chemically and kinetically competent intermediate in the TSase 
reaction7. Subsequently, the finding was reinforced by isolation of the Int-B formed in course of 




Previous studies reported synthesis and biological activity evaluation of the stable analogue of 
Int-B, 8-deaza-5,6,7,8-tetrahydrofolate,9-10 a potent nanomolar competitive inhibitor of human 
TSase. Despite this inhibitor being the closest analog of the naturally occurring intermediate of 
the reaction, no study focused on the structural characterization of its complex with TSase. Such 
structural information would for the first time provide an atomic-level view of the reaction 
caught after formation of the covalent ternary complex Int. In order to explore this possibility, 
we synthesized a potential bisubstrate inhibitor of TSase: 4-amino-8-deaza-Int-B. The inhibitor 
was synthesized as a mixture of diastereomers (6S) and (6R), where C6 is on the folate analog 
moiety. Only the (6S)-diastereomer of CH2H4F (and hence of Int-B) is active; the 4-amino-8-
deaza-Int-B corresponding to active Int-B is the (6S)-diastereomer (referred to further in the text 
as 4A8DZ-Int-B). The diastereomers were separated by C18 HPLC and each was found to 
inhibit EcTSase with IC50 of 4.7 and 17.3 µM for (6S)- and (6R)- diastereomer, respectively 
(Figure S1).  
The two diastereomers, were each co-crystallized with EcTSase, their crystal structures were 
refined at 1.8 Å and 1.55 Å resolution. Further discussion will focus primarily on the structure of 
the (6S) complex. 
The 4A8DZ-Int-B is clearly identifiable in difference density maps only in monomer B (Figure 
2A). It closely resembles the EcTSase·FdUMPCH2H4F structure but apparently is without a 
covalent bond between C6 of dUMP and the catalytic cysteine. Hydrogen bond interactions with 
EcTSase are conserved. A unique crystallographic water molecule (W2) forming the continuous 
H-bond network between Tyr94, Glu58, His147 and Asn177, is observed only 2.9 Å away from 






Figure 2. A. Monomer B active site with the inhibitor built as a statistical mixture of covalently 
(4A8DZ-Int, light) and non-covalently (4A8DZ-Int-B, dark) bound forms. The continuous H-
bond network is outlined between residues Tyr94, Glu58, His147, Asn177, and several 
crystallographic water molecules, including the suggested general base in the reaction – W2.     B. 
Monomer A active site showing the inhibitor resolved into products, 4-amino-8-deaza-H2F and 
dTMP. dTMP is partially occupied; PO4-2 partially occupies the dTMP density. Zoned electron 
density map (2mFo-DFc) is represented as an isomesh at 0.7 sigma. C. Crystal structure-suggested 
partitioning of the 4A8DZ-Int-B in TSase active sites: equilibrium between 4A8DZ-Int-B and its 
covalent C5-protonated form 4A8DZ-Int in the Monomer B, and complete conversion of the 
4A8DZ-Int-B into products in the Monomer A.  
Bridging density for the methylene group is clearly seen between the N5-methylene group of the 




Int-B analog could be best fit to the density when C5 and its substituents were not coplanar, 
suggesting C5 was sp3 hybridized.  
In order to test the feasibility of the bisubstrate intermediate being protonated at C5, hybrid 
hybrid QM/MM free energy surfaces (FES) were generated with the QM region described 
semiempirical and DFT methods, while the protein and the solvent water molecules were 
described with classical force fields (see SI for details). Our selection of QM methods is in 
agreement with the previous findings of Kaiyawet et al., 11 who also pointed out the possible 
relevance of the QM-MM partitioning, and with our previous QM/MM benchmarking on this 
system.12  The QM/MM free energy surfaces generated to explore the C6-Cys146 breaking bond 
without a concomitant proton transfer from the C5 carbon atom (Figure S6A) render structures 
unstable where other unexpected interactions are established. These involve the interaction 
between the active site sulfur atom of Cys146 and either N1 or C2 atoms of dUMP (Fig. S6B). In 
addition, the process involves activation energy barriers (ca. 35 kcal·mol-1, as shown in Fig. S6A) 
too large to provide any competent intermediates. The exploration was carried out with Int-B but 
also with 4A8DZ-Int-B, obtaining the same results. Subsequently, the species observed in the 
monomer B are consistent with a mixture of the intact Int-B analog and its covalent, C5-
protonated form - an analog of Int (Figure 2A). This statistical disorder agrees with weak density 
for C5 and C6 of the pyrimidine, poorly resolved density for O4 and with the presence of weak 
density between the catalytic sulfhydryl and the pyrimidine of the inhibitor. We refined the 
inhibitor as a statistical mixture of Int-B and Int analogs. The C5 of dUMP in the Int-B analog 
is somewhat distorted from sp2 geometry after refinement, which we attribute to strain imposed 




4A8DZ-Int-B in monomer A is more disordered. Bridging density between the N5-methylene 
group of the 4A8DZ-H4F and C5 of dUMP is not visible in density maps, rather, there is a 
methyl group attached to C5 of dUMP. Density for the folate moiety of the inhibitor fits best to 
4-amino-8-deaza-H2F (4A8DZ-H2F, Figure 2B). It therefore appears that in monomer A, 
4A8DZ-Int-B behaves as a substrate and most has been converted to dTMP and 4A8DZ-H2F 
(Figure 2C). Density around some atoms in the ligands, particularly C6 of dTMP is weak or 
absent. The structure that best accounts for the density in the active site assumes dTMP was 
released and replaced by water and a phosphate ion a portion of the time. This interpretation is 
consistent with the disorder of the phosphate-binding loop, which shows the loop alternately in 
its conformation in apo-EcTSase (PDB 1TJS) and in its conformation in the ternary complex.  
Complete turnover of the 4A8DZ-Int-B in the monomer A indicates that chemical alterations 
introduced to halt the reactivity of the Int-B analog were insufficient to fully prevent its 
conversion to the products in at least one active site under the crystallization conditions. Choice 
of the 4-amino and 8-deaza substitutions in the folate part of the molecule was largely dictated 
by an increased stability to nonenzymatic autoxidation provided by these alterations.13 In order to 
determine if the enzymatic oxidation of the 4-amino-8-deaza-moiety of the Int-B analog is also 
hampered in the TSase active site we calculated the QM/MM free energy surface for the hydride 
transfer from C6 of the 4A8DZ-H2F to the exocyclic methylene intermediate (analogous to the 
step 4 in the Figure 1A) and found that the energy barrier for this reaction is essentially the same 
as for the natural reaction, within the uncertainty associated to the method (Figure S7). Since 
QM/MM calculations did not support that the chemical step is perturbed for the Int-B analog, its 
incomplete turnover (only in the monomer A) is more likely a result of the protein allosteric 




Both the natural (6S) and unnatural (6R) diastereomers of the Int-B analogs were able to undergo 
elimination of the H4F analog to give an exocyclic methylene intermediate (see details on (6R)-
isomer structure in the Supporting Information). The exocyclic methylene was subsequently 
either reduced to yield products (in the case of the natural (6S) diastereomer) or undergo addition 
of water to give 5-hydroxymethyl-dUMP (in the case of the (6R) diastereomer). The products of 
these chemical steps were seen only in monomer A, which in both cases has the same 
conformation as in the covalent ternary complex analog EcTSase·FdUMPCH2H4F.  
Both of the Int-B analog complexes  are highly symmetrical dimers, but differences in the 
dynamics of the two protomers may be one basis for activity of only protomer A. In both 
complexes the average B-factors in protomer B are approximately 9 Å2 higher than in protomer 
A; in particular, the B-factor of Trp80, which interfaces with the inhibitor and sequesters the 
active site from bulk solvent,14 is 14 Å2 higher in protomer B than in protomer A. In addition to 
the B-factor differences, the phosphate-binding loop (residues 19-25) in protomer B is shifted ~ 
1 Å out of the active site compared to the active protomer A. Thus, the closed conformation of 
the active site, which is important for catalysis, may be less stable in protomer B.15 
There are also differences between the two protomers in the dynamics of the catalytic Cys146 
and adjacent residues. The NMR titration experiments with the FdUMPCH2H4F di-ligand  
showed that allosteric changes accompanying di-ligand binding that may lead to half-the-sites 
reactivity are mostly transmitted through the β-sheet interface and involve changes to the 
dynamics of the two active sites.16 Consistent with the NMR titration experiments, there are 
subtle differences in the strand containing active site nucleophile, Cys146 in the inactive 
monomer B. In monomer B of both Int-B analog structures, the side chain of Phe149 in this 




adopt alternate conformations (Figure S4). Disorder of these residues has also been seen in the 
asymmetric dimer structure of a ligand-bound EcTSase mutant,17. 
The (6S)-diastereomer of the Int-B analog differs from Int-B only by replacement of O4 and N8 
in the pterin ring by NH2 and CH2, respectively. Neither O4 nor N8 contact the protein in 
EcTSase·FdUMPCH2H4F, so the analog would be expected to bind in the same way as Int-B. 
Thus, the co-crystal structure of EcTSase with the (6S) inhibitor for the first time gives a glimpse 
of a TSase reaction intermediate formed after Int. The asymmetry of the structure validates the 
half-the-sites mechanism of EcTSase and shows that half-site activity occurs before the hydride 
transfer step. 
In summary we structurally characterized for the first time an intermediate in the TSase reaction 
that follows formation of the covalent ternary complex intermediate. The structure is an 
asymmetric dimer in which the bisubstrate analog has partially reacted with the enzyme in only 
one active site. The two protomers have very similar structures. Minor differences at the dimer 
interface and in the active site phosphate-binding loop are the main clues to the asymmetric 
activity. A new water 2.9 Å from C5 of the dUMP moiety in the inactive protomer is part of a 
network of conserved waters and residues that may jointly function to abstract the C5 proton 
prior to methyl transfer.  
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